-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca Stock And 2 Cash Flow Picks Worth A Closer Look

Simply Wall St·08/18/2026 20:22:43
Listen to the news

Global bond yields are lifting as investors respond to higher inflation risk and oil market worries. When borrowing costs climb, many traders focus on short term moves and some cash rich companies get marked down. That opens a window for value hunters. This article looks at three stocks from the Undervalued Stocks Based On Cash Flows screener that the market currently prices cheaply relative to their cash flow potential.

The three stocks that follow are just a small sample, and the full screen surfaced another 43 companies with cash flow profiles and valuation gaps that could be just as interesting for value focused investors. To identify which of these ideas best fit your own checklist, head straight into the Undervalued Stocks Based On Cash Flows screener.

On the Beach Group (LSE:OTB)

On the Beach Group is an online retailer and tour operator that packages short haul beach holidays through its onthebeach.co.uk and sunshine.co.uk platforms, which are the main drivers of its cash flow focused holiday booking model. The group generated £114.2 million from this core UK and Ireland holiday business, making it the key revenue engine behind the SWS “Undervalued Stocks Based On Cash Flows” theme. The stock has a market cap of about £279 million.

For investors looking at cash flow driven value opportunities, On the Beach Group offers an interesting mix of a scalable online platform, recurring package holiday bookings and a recently launched buyback program that can lift the value of each remaining share if executed carefully. The flip side is a funding structure that leans heavily on external sources and an uneven dividend record, which can make cash returns less predictable. Add in rising environmental and regulatory pressure on air travel and this is a business where the cash flow story raises questions about how it can balance growth, risk and capital returns from here.

On the Beach Group’s cash rich booking model and buyback plan could be masking a more complicated capital story. Get the full picture in the 4 key rewards and 2 important warning signs

OTB Discounted Cash Flow as at Aug 2026
OTB Discounted Cash Flow as at Aug 2026

Build your own cash flow shortlist

On the Beach Group and the two other stocks in this article all came from a single Simply Wall St screener, which is only a starting point. Use our flexible Screener to combine cash flow, valuation, balance sheet strength, risks and dividends in a way that suits you, or tap into our curated Investing Ideas for ready made shortlists built around clear themes.

AstraZeneca (LSE:AZN)

AstraZeneca is a global biopharmaceutical company that discovers, develops and sells prescription medicines across oncology, cardiovascular and metabolic disease, respiratory and immunology, vaccines and rare diseases. Its place in the Undervalued Stocks Based On Cash Flows screener comes from the cash flow potential of marketed therapies like Tagrisso, Farxiga/Forxiga, Imfinzi and Lynparza, which underpin discounted cash flow estimates, rather than early stage pipeline hopes alone. The company generates around US$61.4b of revenue from pharmaceuticals and has a market cap of about £179.3b.

Investors looking at AstraZeneca today are getting exposure to a large portfolio of marketed cancer and chronic disease drugs that already generate cash. The DCF work from Simply Wall St suggests the stock trades well below estimated fair value if those cash flows keep coming. Profit margins and return on equity are solid, yet the company carries a hefty debt load and has seen insider selling in recent months, which could matter if funding costs rise. When combined with recent trial wins and setbacks in oncology, this creates a complex mix of quality cash flows, pipeline optionality and risk that is not fully captured in a simple share price chart.

AstraZeneca’s cash generating drug portfolio and discounted valuation can look like a puzzle that the share price has not fully solved yet. Get the full analysis report for AstraZeneca for the crucial twist around debt, margins and pipeline risk that most investors overlook

AZN Discounted Cash Flow as at Aug 2026
AZN Discounted Cash Flow as at Aug 2026

Foresight Group Holdings (LSE:FSG)

Foresight Group Holdings is an asset manager focused on real assets and private equity, with a strong link to the screener theme through its renewable infrastructure business that runs cash generating solar, onshore wind, battery storage and energy management projects valued using DCF methods. The group earns most of its revenue from Real Assets at about £114.8 million, with Private Equity contributing around £50.1 million, and has a market cap of roughly £548 million.

Foresight Group Holdings may interest you if you want exposure to cash flows backed by real infrastructure rather than purely financial engineering. The renewable assets that feed into the Real Assets segment help support relatively steady cash generation, while private equity and newer credit products add higher fee potential and scope for AUM growth. Set against that are rising administrative costs, reliance on external borrowing and performance fees, and a heavier focus on UK and European policy for renewables. Recent buybacks and earnings growth suggest that there is more to the story than the current share price reflects, but the key consideration is how durable those cash flows and capital returns may be over the next few years.

Foresight Group Holdings is pricing in real asset cash flows that many investors may be underestimating. See how the analysis report for Foresight Group Holdings frames those renewable projects, rising costs and buybacks before the story shifts again.

FSG Discounted Cash Flow as at Aug 2026
FSG Discounted Cash Flow as at Aug 2026

Seeking Fresh Alternatives Before Others Catch On

Markets move fast and the best cash flow stories can gain breakout momentum before most investors even notice. Review these fresh, curated stock ideas while they may still be timely and consider them early in your process.

  • Identify companies quietly building strength before momentum headlines appear by reviewing a focused group of 6 resilient stocks with low risk scores that keep financial risk in check while others chase hype.
  • Explore potential income opportunities while yields may still be flying under the radar by scanning a curated pool of 7 dividend fortresses built around durable balance sheets and reliable cash coverage.
  • Monitor early movers participating in the shift toward electrification before valuations move higher by checking a hand picked mix of 9 top copper producer stocks tied to long term demand themes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.